Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective: Adherence to adjuvant endocrine therapy in women with breast cancer is low, and patients are not informed sufficiently. This study analyzes the effects of a structured treatment information on patients' satisfaction, knowledge, and adherence. Methods: An interventional single cohort study of postoperative women with estrogen‐receptor‐positive breast cancer was conducted to study the effects of enhanced information about endocrine therapy given additionally to clinical routine information. Knowledge and satisfaction with additional information given 1–3 weeks after surgery were assessed before and after informing patients; adherence and knowledge were measured 3 months after start of treatment. Results: A total of 137 patients were analyzed before and after provision of enhanced treatment information as well as 3 months after start of endocrine therapy. Enhanced information increased satisfaction with information and knowledge. The percentage of patients who knew their estrogen receptor status increased from 50% to 93%. At 3 months follow‐up, 60% still had correct knowledge. Patients who learned their receptor status were older, and those who forgot had lower cognitive abilities and lower educational level. Patients with higher satisfaction, better learning, and comprehension directly after enhanced information showed better adherence at 3 months follow‐up. Conclusion: Patients, especially older ones, can benefit from enhanced treatment information given additionally to routine care. Enhanced information about mode of action and potential side effects of endocrine therapy when included into clinical routine might foster patient autonomy and prevent early disruptions in adherence. Copyright © 2014 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring Numeracy without a Math Test: Development of the Subjective Numeracy Scale
Fagerlin, A., Zikmund-Fisher, B. J., Ubel, P. A., Jankovic, A., Derry, H. A., & Smith, D. M. (2007) · Medical Decision Making · doi:10.1177/0272989x07304449 · Cited by 960 · cited 1×
“Cognitive ability and numeracy were assessed by Multiple Choice Word Test [27] and Subjective Numeracy Scale [28].”
MethodInformation needs of patients with cancer: results from a large study in UK cancer centres
Jenkins, V, Fallowfield, L., & Saul, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1573 · Cited by 845 · cited 1×
“In line with other studies, this shows that most patients with breast cancer wish to receive as much and detailed medical information as possible, independent of valence of information [22,23,31,32].”
ResultNonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676 · cited 1×
“One year after start of AET, 77% of patients are adherent and only 50% after 4 years of treatment [6].”
BackgroundAdherence to endocrine therapy for breast cancer
Chlebowski, R. T., & Geller, M. L. (2006) · Oncology · doi:10.1159/000100444 · Cited by 251 · cited 1×
“Notably, there is a high rate of non-adherence to AET [6–8].”
BackgroundPatient Centered Experiences in Breast Cancer: Predicting Long-Term Adherence to Tamoxifen Use
Kahn, K. L., Schneider, E. C., Malin, J. L., Adams, J. L., & Epstein, A. M. (2007) · Medical Care · doi:10.1097/01.mlr.0000257193.10760.7f · Cited by 245 · cited 4×
“Receiving the right amount of information and having knowledge of the treatment and its potential side effects are preconditions for shared decision making, which also plays an important role in increasing adherence in AET [17,18,22].”
BackgroundResultInfluentialCluze, C., Rey, D., Huiart, L., BenDiane, M. K., Bouhnik, A. D., Berenger, C., Carrieri, M. P., & Giorgi, R. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr330 · Cited by 133
Ziller, V., Kyvernitakis, I., Knöll, D., Storch, A., Hars, O., & Hadji, P. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-407 · Cited by 82 · cited 1×
“The finding that those who forgot their ER status had lower cognitive abilities and less education suggests that healthcare providers should repeatedly discuss the mode of action and importance of AET during the course of treatment [36].”
Background
Cited by
Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.8619 · Cited by 244
Nestoriuc, Y., von Blanckenburg, P., Schuricht, F., Barsky, A. J., Hadji, P., Albert, U.-S., & Rief, W. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw266 · Cited by 103
Self-citationTamoxifen in men: a review of adverse events
Wibowo, E., Pollock, P. A., Hollis, N., & Wassersug, R. J. (2016) · Andrology · doi:10.1111/andr.12197 · Cited by 97
“Studies in women with breast cancer suggest that informing patients about treatment-related AEs can help adherence to treatment (Heisig et al., 2014) and better management of AEs (Cella & Fallowfield, 2008).”
BackgroundKube, T., Rozenkrantz, L., Rief, W., & Barsky, A. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101829 · Cited by 91
Self-citationA systematic review of interventions to improve adherence to endocrine therapy
Heiney, S. P., Parker, P. D., Felder, T. M., Adams, S. A., Omofuma, O. O., & Hulett, J. M. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5012-7 · Cited by 69
Metadata
- Authors
- Heisig, S. R., Shedden‐Mora, M. C., von Blanckenburg, P., Schuricht, F., Rief, W., Albert, U., & Nestoriuc, Y.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2014-06-21
- Volume
- 24
- Issue
- 2
- Pages
- 130-137
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W1910543239
- Cited by
- 72
- References
- 7
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.